Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
DITROPAN XL
Generic name / active ingredient
oxybutynin chloride extended-release tablets
Dosage-form class
Oxybutynin chloride osmotic extended-release oral tablets: 5 mg, 10 mg or 15 mg per tablet; swallow whole and do not chew, divide or crush; not an immediate-release tablet, syrup or transdermal patch
Route
Oral
Record reviewed
2026-08-29

Copy from the pack in hand

Source-linked reading points

  • 5, 10 and 15 mg are labelled amounts per tablet, not an individual's tablet count. Although two 5 mg numbers add to 10 mg, that does not permit self-assembling tablets, changing an amount, replacing a 10 mg product or copying another person's prescription.
  • Keep the tablet intact; do not split, cut, chew, dissolve or crush it. For swallowing difficulty, take the exact pack and prescription to a pharmacist or prescriber instead of disrupting extended release or self-switching to syrup, immediate-release tablets or a patch.
  • Dry mouth, constipation, inability to urinate, drowsiness, dizziness, blurred vision, confusion or hallucinations may relate to anticholinergic effects. Older adults, people with cognitive impairment and those using sleeping, allergy, nausea, bladder or other anticholinergic medicines need priority review of the complete medicine list.
  • Swelling of the face, lips, tongue or throat or difficulty breathing needs emergency help. Reduced sweating, high temperature or mental-status change in heat can also be serious. Severe constipation, distension, inability to pass stool or gas, or urinary retention needs prompt medical assessment.

Reviewed presentation examples — compare every field

  • Oxybutynin chloride 5 mg per tablet; U.S. originator RLD discontinuedNDA 020897 / Product 001
  • Oxybutynin chloride 10 mg per tablet; U.S. originator RLD discontinuedNDA 020897 / Product 002
  • Oxybutynin chloride 15 mg per tablet; U.S. originator RLD discontinuedNDA 020897 / Product 003

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-29
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image